LC-DAD-APCI-MS-based screening and analysis of the absorption and metabolite components in plasma from a rabbit administered an oral solution of danggui
- 363 Downloads
A valid chromatographic fingerprint method using liquid chromatography-diode array detection-atmospheric pressure chemical ionization mass spectrometry in negative mode (LC-DAD-APCI-MS) is proposed for studying the absorption and metabolites of a traditional Chinese medicine (TCM) Angelica sinensis (danggui) in rabbit plasma, after the rabbit is administered with danggui oral solution (DOS). More than thirty-two common components were detected in both DOS and rabbit plasma, which shows that the components in the DOS were absorbed into the body of the rabbit. Of these, senkyunolide I, senkyunolide H, Z-6,7-epoxyligustilide, 3-butylidene-7-hydroxyphthalide, Z-ligustilide, Z-butylidenephthalide, Diels-Alder dimers of ligustilide, linolenic acid, linoleic acid and falcarindiol were tentatively identified from their MS, UV spectra and retention behavior by comparing the results with the published literature. At least ten components were found in rabbit plasma but not in DOS, indicating that these components must be metabolites of some of the components in the original extract. The results prove that the proposed method can be used to rapidly analyze multiple constituents in TCMs, and to screen for bioactive compounds by comparing and contrasting the chromatographic fingerprints of DOS and plasma samples.
KeywordsChromatographic fingerprint Screen and analyze Absorption and metabolite components Danggui oral solution Rabbit plasma
We are very grateful to Dr. Ying-Dong Li (College of Gansu Traditional Chinese Medicine) for supplying plant material. The National Natural Science Foundation of China (Grants No. 20235020), the Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (No. 704036) and Natural Science Foundation of Gansu province (GS022-A43-138) financially supported this research work.
- 1.Zheng ZH, Dong ZH, She J (eds) (1997) Chinese herb medicine modern study and application, vol 1. Xueyuan Publishing House, Beijing, pp 1807–1859Google Scholar
- 2.Wangner H, Bauer R, Xiao PG, Chen JM (2001) Chinese drug monographs and analysis, vol 3, no. 14. Verlag für Ganzheitliche Medizin, Kotzting/Bayer, Wald, 14:1–8Google Scholar
- 3.Jiangsu New Medicinal Academy (eds) (2003) Chinese traditional medicinal big thesaurus. Shanghai Publishing House of Science and Technology, ShanghaiGoogle Scholar
- 4.Huang WH, Song CQ (2001) Chin J Chin Materia Medica 26:147–155Google Scholar
- 5.Chen YZ, Zhang HD (1984) Chem J Chin Univ 5:515–519Google Scholar
- 6.Lin M, Zhu CD, Sun QM, Fang QC (1979) Chin J ACTA Pharmaceutical Sinica 14:529–533Google Scholar
- 9.Liu XD, Xue YY, Xie L, Ji HF, Wang GJ (2003) J China Pharmaceutical University 34:448–451Google Scholar
- 10.Luo HM, Li XG, Xiao F, Gu F (2003) J Chin Med Mater 26:189–192Google Scholar
- 12.US FDA (2000) Guidance for industry—Botanical drug products (Draft guidance). US Food and Drug Administration, Rockville, MD, vol VIII, B18Google Scholar
- 13.Xie PS (ed) (2005) Chromatographic fingerprinting of traditional Chinese medicine. People's Medical Publishing House, BeijingGoogle Scholar